GAVISCON FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

Download full text PDF
Issue: 
5
Year: 
2015

T. Potupchik (1), Candidate of Medical Sciences; O. Veselova (1), Candidate of Medical Sciences; L. Evert (2), MD 1 -Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2 -Research Institute for Medical Problems of the North, Krasnoyarsk

The alginate Gaviscon® may be used in the symptomatic treatment of dyspepsia associated with gastric hyperacidity, as well as gastroesophageal reflux disease.
Keywords: 
gastroesophageal reflux disease
sodium alginate
Gaviscon®
antacids
acid pocket

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bordin D.S. «Kislotnyj karman» kak patogeneticheskaja osnova i terapevticheskaja mishen' pri gastroezofageal'noj refljuksnoj bolezni // Ter. arh. – 2014; 2: 76–80.
  2. Bordin D.S., Masharov A.A., Kozhurina T.S. Lechenie gastroezofageal'noj refljuksnoj bolezni al'ginatami // Lechaschij vrach. – 2008; 6: 93–4.
  3. Bordin D.S., Masharova A.A., Firsova L.D. i dr. Otsenka skorosti nachala dejstvija i kupirovanija izzhogi pri odnokratnom prieme al'ginatov u bol'nyh GERB // Eksper. i klin. gastroenterol. – 2009; 4: 83–91.
  4. Bulgakov S.A. Geviskon pri izzhoge, obuslovlennoj gastroezofageal'goj refljuksnoj bolezn'ju // Farmateka. – 2011; 20: 54–8.
  5. Vasil'ev Ju.V., Masharova A.A., Janova O.B. i dr. Opyt primenenija Geviskona v ustranenii zheludochno-pischevodnogo refljuksa u bol'nyh gastroezofageal'noj refljuksnoj bolezn'ju // Consilium Medicum. Gastroenterologija. – 2008; 2: 3–5.
  6. Vjalov S.S., Chorbinskaja S.A. Gastroezofageal'naja refljuksnaja bolezn' (GERB): diagnostika, lechenie i profilaktika. Metod. rekomendatsii / M., 2011; 16 c.
  7. Isakov V.A., Morozov S.V., Stavraki E.S. i dr. Analiz rasprostranennosti izzhogi: natsional'noe epidemiologicheskoe issledovanie vzroslogo gorodskogo naselenija (ARIADNA) // Eksper. i klin. gastroenterol. – 2008; 1: 20–9.
  8. Kajbysheva V.O., Truhmanov A.S., Ivashkin V.T. Gastroezofageal'naja 8. refljuksnaja bolezn', rezistentnaja k terapii ingibitorami protonnoj pompy // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2011; 4: 4–13.
  9. Kotljarova V.V., Pchel'nikov Ju.V., Ljal'kova V.P. Osobennosti sbora anamneza pri retsidivirujuschih bronholegochnyh zabolevanijah u detej asso-tsiirovannyh s GERB. Sb. trudov konferentsii Dostizhenija fundamental'noj, klinicheskoj meditsiny i farmatsii. Vitebsk, 2015.
  10. Lazebnik L.B., Bordin D.S., Masharova A.A. i dr. Vosstanovlenie kachstva zhizni ustraneniem i predotvrascheniem izzhogi «al'ginatom»: rezul'ta-ty mnogotsentrovogo issledovanija «VIA APIA» // Eksper. i klin. gastroente-rol. – 2010; 6: 70–6 .
  11. Lazebnik L.B., Masharova A.A., Bordin D.S. i dr. Rezul'taty mnogtsentrovogo issledovanija «Epidemiologija gastroezofageal'noj refljuks-noj bolezni v Rossii» (MEGRE) // Ter. arh. – 2011; 16: 45–50
  12. Onuchina E.V. Klinicheskie projavlenija, faktory riska i effektiv- nost' lechenija gastroezofageal'noj refljuksnoj bolezni u lits pozhilogo vozrasta. Avtoref. dis. ... d-ra med. nauk. Krasnojarsk, 2011; s. 45.
  13. Onuchina E.V., Brikova S.I., Tsukanov V.V. Sravnitel'noe issledovanie al'ginatnogo i antatsidnogo preparatov dlja rannej simptomaticheskoj terapii gastroezofageal'noj refljuksnoj bolezni u lits pozhilogo i starcheskogo vozrasta // Consilium Medicum. Gastroenterologija. – 2010; 2: 6–11.
  14. Onuchina E.V., Tsukanov V.V. Vnepischevodnye projavlenija i ih rannjaja simptomaticheskaja terapija u pozhilyh bol'nyh gastroezofageal'noj ref-ljuksnoj bolezn'ju // Vrach. – 2014; 3: 73–7.
  15. Pahomova I.G., Tkachenko E.I., Uspenskij Ju.P. Pervyj v Rossii opyt ispol'zovanija Geviskona v lechenii gastroezofageal'noj refljuksnoj bolezni // RMZh. – 2007; 22: 1639–45.
  16. Privorotskij V.F., Luppova H.E. Kislotozavisimye zabolevanija u detej (klinicheskaja kartina, diagnostika, lechenie): uchebn. posob. / SPb: SPbMAPO, 2005.
  17. Privorotskij V.F., Luppova N.E., Gerasimova T.A. i dr. Gastroezofageal'naja refljuksnaja bolezn' (GERB) u detej // Eksperim. i klin. gastroenterologija. – 2011; 1: 14–21.
  18. Starostin B.D. Patogeneticheski napravlennaja terapija GERB// Vrach. – 2015; 1: 36–9.
  19. Beaumont H., Bennink R., de Jong J. et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GOLD // Gut. – 2010; 59: 441–51.
  20. Clarke A., Wirz A., Manning J. et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket // Gut. – 2008; 57: 292–7.
  21. Dettmar P., Hampson F., Jain A. et al. Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole // Indian J. Med. Res. – 2006; 123 (4): 517–24.
  22. El-Serag H., Sweet S., Winchester C. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review // Gut. – 2013; Jul 13.
  23. Epub.ahead of print.Kahrilas P. Gastroesophageal reflux disease // JAMA. – 1996; 276: 983–8.
  24. Kapadia C., Mane V. Raft-forming agents: antireflux formulations // Drug. Dev. Ind. Pharm. – 2007; 33 (12): 1350–61.
  25. Kwiatek M., Roman S., Fareeduddin A. et al. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial «acid pocket» in symptomatic GERD patients // Aliment. Pharmacol. Ther. – 2011; 34: 59–66.
  26. Moayyedi P., Talley N. Gastroesophageal reflux disease // Lancet. – 2006; 367: 2086–100.
  27. Namasiovayam V., Katzka D. Extraesophageal reflux Definition and Pathophysiology. In: A. DiMarino Jr., S. Cohen, eds. Extraesophageal Manifestations of GERD. Slack Incorporated, 2013; 1–19.
  28. Pandolfino J. et al. Acidity Surrounding the Squamocolumnar Junction in GERD Patients: «Acid Pocket» Versus «Acid Film» // Am. J. Gastroenterol. – 2007; 102: 263–4.
  29. Tytgat G., Mccoll K., Tack J. et al. New algorithm for the treatment of gastro esophageal re ux disease // Aliment. Pharmacol. Ther. – 2008; 27: 249–56.
  30. Van Pinxteren B., Numans M., Bonis P. et al. Short term treatment with proton pump inhibitors, H2RAs and prokinetics for gastrooesophageal reflux diseaseike symptoms and endoscopy negative reflux disease // Cochrane Database Syst. Rev. – 2004; 3:CD 002095.